# Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells

> **NCT00523393** · PHASE4 · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 75 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Insulin Glargin
- **DRUG:** Human Insulin

## Key facts

- **NCT ID:** NCT00523393
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** 2009-12
- **Final completion:** 2010-05
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2009-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523393, "Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00523393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*